RAPT Therapeutics Inc. (RAPT)
NASDAQ: RAPT
· Real-Time Price · USD
23.95
2.99 (14.27%)
At close: Sep 24, 2025, 3:59 PM
23.93
-0.08%
After-hours: Sep 24, 2025, 07:38 PM EDT
14.27% (1D)
| Bid | 21 |
| Market Cap | 396.08M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -106.49M |
| EPS (ttm) | -14.8 |
| PE Ratio (ttm) | -1.62 |
| Forward PE | -6.6 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 25 |
| Volume | 199,485 |
| Avg. Volume (20D) | 126,890 |
| Open | 21.66 |
| Previous Close | 20.96 |
| Day's Range | 21.64 - 23.98 |
| 52-Week Range | 5.66 - 26.56 |
| Beta | -0.10 |
| Ex-Dividend Date | n/a |
About RAPT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RAPT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RAPT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts9 months ago
+110.91%
RAPT Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
10 months ago
-39.45%
RAPT Therapeutics shares are trading lower after the company terminated its Zelnecirnon program following an FDA clinical hold due to a severe adverse event involving liver injury.
